Scott Hirsch serves as Executive at Keenova Therapeutics plc, where they oversee executive responsibilities. Since joining the company, Scott Hirsch has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 23, 2026 involved receiving (via award) 3,984 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Feb 23, 2026 | NONE | $0 | Award | 3,984 | $N/A | Discretionary |
Scott Hirsch currently holds 8,866 shares of Keenova Therapeutics plc (NONE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Scott Hirsch has been a net neutral trader of NONE stock. They have purchased $0 and sold $0 worth of shares.
Scott Hirsch's most recent insider trade was on Feb 23, 2026, when they sold 3,984 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted